UA99678C2 - COMBINATION DOSAGE FORM CONTAINING A TAMSULOSIN AND TESTOSTERONE-5a-REDUCTASE INHIBITOR - Google Patents
COMBINATION DOSAGE FORM CONTAINING A TAMSULOSIN AND TESTOSTERONE-5a-REDUCTASE INHIBITORInfo
- Publication number
- UA99678C2 UA99678C2 UAA201107271A UAA201107271A UA99678C2 UA 99678 C2 UA99678 C2 UA 99678C2 UA A201107271 A UAA201107271 A UA A201107271A UA A201107271 A UAA201107271 A UA A201107271A UA 99678 C2 UA99678 C2 UA 99678C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pellets
- tamsulosin
- population
- dosage form
- form containing
- Prior art date
Links
- DRHKJLXJIQTDTD-OAHLLOKOSA-N Tamsulosine Chemical compound CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 DRHKJLXJIQTDTD-OAHLLOKOSA-N 0.000 title abstract 3
- 229960002613 tamsulosin Drugs 0.000 title abstract 3
- 239000002552 dosage form Substances 0.000 title abstract 2
- 229940123934 Reductase inhibitor Drugs 0.000 title 1
- 239000008188 pellet Substances 0.000 abstract 8
- ZZIZZTHXZRDOFM-UHFFFAOYSA-N 2-(2-ethoxyphenoxy)ethyl-[1-(4-methoxy-3-sulfamoylphenyl)propan-2-yl]azanium;chloride Chemical compound Cl.CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 ZZIZZTHXZRDOFM-UHFFFAOYSA-N 0.000 abstract 2
- 229960003198 tamsulosin hydrochloride Drugs 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a population of tamsulosin-comprising pellets for oral administration of a combination dosage form containing physically separated a tamsulosin dose in the form of the population of the tamsulosin comprising pellets and at least one other dose of a pharmaceutically active substance, said pellets comprising tamsulosin hydrochloride uniformly dispersed in a carrier matrix, wherein (i) said pellets in the population have a size of less than about 1.4 mm and, advantageously, at least 90 % of the pellets have a size of larger than 0.30 mm; and (ii) an average content of tamsulosin hydrochloride in the population of pellets is between about 0.15-3.00 weight percent, calculated on a dry pellet basis, to a process of making such population of pellets, and to their use.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201107271A UA99678C2 (en) | 2008-12-09 | 2008-12-09 | COMBINATION DOSAGE FORM CONTAINING A TAMSULOSIN AND TESTOSTERONE-5a-REDUCTASE INHIBITOR |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201107271A UA99678C2 (en) | 2008-12-09 | 2008-12-09 | COMBINATION DOSAGE FORM CONTAINING A TAMSULOSIN AND TESTOSTERONE-5a-REDUCTASE INHIBITOR |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA99678C2 true UA99678C2 (en) | 2012-09-10 |
Family
ID=50850210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201107271A UA99678C2 (en) | 2008-12-09 | 2008-12-09 | COMBINATION DOSAGE FORM CONTAINING A TAMSULOSIN AND TESTOSTERONE-5a-REDUCTASE INHIBITOR |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA99678C2 (en) |
-
2008
- 2008-12-09 UA UAA201107271A patent/UA99678C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009008952A (en) | Pellets comprising an active substance matrix resistant to gastric juice. | |
| RU2009106681A (en) | GRANULAR PHARMACEUTICAL COMPOSITIONS | |
| NI201300054A (en) | ENCLOSED CONTROLLED RELEASE DOSE FORMS RESISTANT TO IMPROPER HANDLING | |
| NZ594022A (en) | Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof | |
| MX2008000099A (en) | Modified release pharmaceutical compositions on the basis of two polymers and processes thereof. | |
| PE20061017A1 (en) | PHARMACEUTICAL FORMULATION BY DIRECT COMPRESSION OF A DIPEPTIDIL-PEPTIDASE IV INHIBITOR AND PROCESS | |
| CR11724A (en) | AGENT TO TREAT DISEASES | |
| MX2007006212A (en) | Oral medicament for the modified release of at least one active principle, in multimicrocapsule form. | |
| BRPI0403935A (en) | Azithromycin dosage forms with reduced side effects | |
| EA201170784A1 (en) | TAMSULUS GRANULES FOR FIXED COMBINATION | |
| MY149156A (en) | Solid dosage form comprising proton pump inhibitor and suspension made thereof | |
| AR038899A1 (en) | A MEDICINAL PRODUCT FOR ANIMALS | |
| MX2010008138A (en) | Pharmaceutical dosage form. | |
| EP2477608A4 (en) | SOLID ORAL DOSAGE FORM CONTAINING NANOPARTICLES AND PROCESS FOR FORMULATING THE SAME WITH FISH GELATIN | |
| EA200700049A1 (en) | PREPARATIVE FORMS OF ORAL MEDICINAL FORMS OF MEMANTINE WITH MODIFIED SURVIVAL | |
| WO2006002365A3 (en) | Microparticles with high loadings of a bioactive agent | |
| MX363495B (en) | Process of manufacturing a lyophilized fast dissolving, muti-phasic dosage form. | |
| MY147641A (en) | Fast release paracetamol tablets | |
| WO2009032887A1 (en) | Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol | |
| MY136136A (en) | Pharmaceutical compositions containing terbinafin and use thereof | |
| NZ596064A (en) | Fixed dose drug combination formulations | |
| SI1677777T1 (en) | Pellets containing venlafaxine hydrochloride | |
| MX2010004962A (en) | Homogeneous and storage-stable mixtures of different active plant protection agent granule particles. | |
| MX2008002512A (en) | Drug compositions containing controlled release hypromellose matrices. | |
| AU2014226192A8 (en) | Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles |